iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials

iShares Nasdaq Biotechnology (NASDAQ: IBB) March weekly call option implied volatility is at 24, April is at 20; compared to its 52-week range of 15 to 40 after Biogen (BIIB) discontinues two Alzheimer's trials. Call put ratio 1 call to 3.3 puts with focus on June 100 puts.

You May Also Be Interested In

• Varonis Systems (VRNS) 1500 contracts of June 70 calls trade, share price up 11.5%
• Hilton (HLT) call put ratio 1.2 calls to 1 put
• C3 AI (AI) call put ratio 4 calls to 1 put with a focus on September 4 weekly 11 calls into quarter results